日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Promoting Employment Participation for People With Mental Health Challenges: Photovoice and Advocacy

促进精神健康障碍人士就业参与:摄影发声与倡导

Wu, Chinyu; Gray, Anna; Paleo, Janet; Dziuk, Madison; Ruiz-Sandoval, Jennifer; Pavitt, Laura

Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study

托法替尼减量治疗稳定缓解期溃疡性结肠炎患者疗效结果的潜在预测因素:RIVETING 研究结果的事后分析

Torres, Joana; D'Haens, Geert R; Regueiro, Miguel; Santana, Genoile; Panés, Julian; Vermeire, Séverine; Gardiner, Sean; Kulisek, Nicole; Modesto, Irene; Su, Chinyu; Lawendy, Nervin; Mundayat, Rajiv; Paulissen, Jerome; Dubinsky, Marla C

Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice

利用基于AAV5的呼吸道合胞病毒疫苗在小鼠体内诱导中和抗体反应

Gangyuan Ma ,Zeping Xu ,Chinyu Li ,Feng Zhou ,Bobo Hu ,Junwei Guo ,Changwen Ke ,Liqing Chen ,Guilin Zhang ,Hungyan Lau ,Hudan Pan ,Xixin Chen ,Runze Li ,Liang Liu

Development and Validation of a Visualized Posture Risk Assessment Questionnaire for Low Back Pain in Daily Activities: A Study in Taiwan

台湾一项关于日常活动中腰痛可视化姿势风险评估问卷的开发与验证研究

Chang, Yu-Tzu; Chen, Yi-Ju; Ho, Chinyu; Yeh, Chienyu; Huang, Cheng-Jung; Lee, Jason Jiunshiou

Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme

托法替尼治疗溃疡性结肠炎:全球临床项目长达 7.8 年安全性数据的综合总结

Sandborn, William J; D'Haens, Geert R; Sands, Bruce E; Panaccione, Remo; Ng, Siew C; Lawendy, Nervin; Kulisek, Nicole; Modesto, Irene; Guo, Xiang; Mundayat, Rajiv; Su, Chinyu; Vranic, Ivana; Panés, Julian

Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme

根据基线心血管风险评估接受托法替尼治疗的溃疡性结肠炎患者的主要不良心血管事件:来自 OCTAVE 临床项目的数据

Schreiber, Stefan; Rubin, David T; Ng, Siew C; Peyrin-Biroulet, Laurent; Danese, Silvio; Modesto, Irene; Guo, Xiang; Su, Chinyu; Kwok, Kenneth K; Jo, Hyejin; Chen, Yan; Yndestad, Arne; Reinisch, Walter; Dubinsky, Marla C

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program

在溃疡性结肠炎项目中,接受托法替尼治疗的溃疡性结肠炎患者发生艰难梭菌感染的情况

Loftus, Edward V; Baumgart, Daniel C; Gecse, Krisztina; Kinnucan, Jami A; Connelly, Susan B; Salese, Leonardo; Su, Chinyu; Kwok, Kenneth K; Woolcott, John C; Armuzzi, Alessandro

Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program

C反应蛋白和部分Mayo评分与托法替尼诱导治疗反应的相关性:溃疡性结肠炎临床项目的结果

Dubinsky, Marla C; Magro, Fernando; Steinwurz, Flavio; Hudesman, David P; Kinnucan, Jami A; Ungaro, Ryan C; Neurath, Markus F; Kulisek, Nicole; Paulissen, Jerome; Su, Chinyu; Ponce de Leon, Dario; Regueiro, Miguel

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

在托法替尼临床开发项目中,类风湿性关节炎、溃疡性结肠炎或银屑病关节炎患者的流感不良事件

Winthrop, Kevin L; Yndestad, Arne; Henrohn, Dan; Danese, Silvio; Marsal, Sara; Galindo, Maria; Woolcott, John C; Jo, Hyejin; Kwok, Kenneth; Shapiro, Andrea B; Jones, Thomas V; Diehl, Annette; Su, Chinyu; Panés, Julian; Cohen, Stanley B

Presence of risk factors associated with colectomy among patients with ulcerative colitis: a post hoc analysis of data from the tofacitinib OCTAVE ulcerative colitis clinical program

溃疡性结肠炎患者结肠切除术相关风险因素的存在:托法替尼OCTAVE溃疡性结肠炎临床项目数据的回顾性分析

Rubin, David T; Salese, Leonardo; Cohen, Mitchell; Kotze, Paulo G; Woolcott, John C; Su, Chinyu; Mundayat, Rajiv; Paulissen, Jerome; Torres, Joana; Long, Millie D